India Pharma Outlook Team | Monday, 01 December 2025
Biotechnology is poised to significantly enhance Maharashtra's health sciences ecosystem, as the state government plans to establish a cutting-edge Life Sciences Innovation and Incubation Centre designed to expedite research and development within the pharmaceutical industry.
During a review meeting at Mantralaya in Mumbai, Food and Drug Administration (FDA) Minister Narahari Zirwal revealed this initiative.
Also Read: Sun Pharma Launches Ilumya in India for Severe Psoriasis
Zirwal noted that states like Gujarat, Andhra Pradesh, and Himachal Pradesh have already created similar research hubs, and that public–private partnerships are being utilized to develop formulation laboratories for biological and chemical research in pharmaceuticals. He emphasized that Maharashtra must act quickly to retain its leadership in innovative drug manufacturing.The proposed centre will facilitate advanced work in pharmaceuticals, biotechnology, medical devices, diagnostics, and digital health, offering startups access to state-of-the-art laboratories, technical expertise, and financial support."The Innovation Park is essential at this time. It will ensure Maharashtra remains at the forefront of innovative drug development," Zirwal stated.Officials indicated that the centre will attract increased investment into the state's pharmaceutical manufacturing sector, generate job opportunities, and enhance training and mentorship for emerging startups. Designed to be a world-class research institution, it will aid in the development of globally competitive pharmaceutical products.
The government is of the opinion that the suggested Innovation and Incubation Centre will act as a significant catalyst in the transformation of Maharashtra into a worldwide center for health, pharmaceutical, and biotech innovation.